查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球數位生物標記市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1346868

全球數位生物標記市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Digital Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 281 Pages | 商品交期: 最快1-2個工作天內

價格

全球數位生物標記市場需求預計將從 2022 年的 36 億美元增至 2030 年的近 194.8 億美元，2023-2030 年研究期間年複合成長率為 23.5%。

數位生物標記是指通過數位設備和技術（包括穿戴式設備、智慧手機、感測器和其他聯網工具）收集的可測量和可量化的健康相關數據。這些數據點用於即時監控和分析個人健康和行為的各個方面。這些生物標記為人們的生理、心理和行為模式提供了寶貴的見解，使醫療保健專業人員和研究人員能夠更全面地了解他們的健康狀況。

市場動態：

由於多種因素推動技術融入醫療保健，數位生物標記市場正在經歷強勁成長。穿戴式設備、遠程監控和數據分析的進步使得即時健康數據的收整合為可能，為數位生物標記物奠定了基礎。這些生物標記有助於個性化醫療保健、預防方法和健康問題的早期發現。智慧手機的廣泛採用，加上人口老齡化和慢性疾病的增加，刺激了對遠程監控解決方案的需求。這些生物標記還在心理健康監測和臨床試驗中發揮了作用，而監管支持和消費者意識進一步推動了它們的採用。儘管如此，數據隱私和準確性等挑戰仍然需要引起關注。技術、醫療保健需求和患​​者賦權的融合支撐著不斷擴大的數位生物標記市場，徹底改變了醫療保健服務和研究方法。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球數位生物標記市場的每個細分市場進行了包容性評估。數位生物標記行業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲數位生物標記市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。數位生物標記市場的主要參與者包括ActiGraph LLC、AliveCor Inc.、Koneksa、Altoida Inc.、Amgen Inc.、Biogen Inc.、Empatica Inc.、Vivo Sense、IXICO plc、Aderium Limited、Neurotrack Technologies, Inc.、 Aural Analytic、Huma、Sonde Health, Inc. 本部分包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布、以及其他進展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：數位生物標記 - 行業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 行業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 通過臨床實踐進行的市場吸引力分析
    • 按治療領域分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷管道發展趨勢

第 5 章：全球數位生物標記市場分析：按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 穿戴式
  • 基於移動的應用程式
  • 感測器
  • 其他

第 6 章：全球數位生物標記市場分析：根據臨床實踐

  • 臨床實踐概述
  • 歷史和預測數據
  • 臨床實踐分析
  • 診斷數位生物標記
  • 監測數位生物標記
  • 預測和預後數位生物標記
  • 其他（安全性、藥效動力學/反應、敏感性）

第 7 章：全球數位生物標記市場分析：按治療領域

  • 按治療領域概述
  • 歷史和預測數據
  • 按治療領域分析
  • 心血管和代謝紊亂 (CVMD)
  • 呼吸系統疾病
  • 精神疾病
  • 睡眠與運動疾病
  • 神經系統疾病
  • 肌肉骨骼疾病
  • 其他（糖尿病、疼痛管理）

第 8 章：全球數位生物標記市場分析：按最終用途

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 醫療保健公司
  • 醫療保健機構
  • 付款人
  • 其他（患者、護理人員）

第 9 章：全球數位生物標記市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家/地區銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家/地區銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家/地區銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：數位生物標記公司的競爭格局

  • 數位生物標記市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • ActiGraph LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AliveCor Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Koneksa
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Altoida Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Amgen Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Biogen Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Empatica Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Vivo Sense
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • IXICO plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Adherium Limited
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Neurotrack Technologies Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Aural Analytic
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Huma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sonde Health Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

Product Code: VMR112111961

The global demand for Digital Biomarkers Market is presumed to reach the market size of nearly USD 19.48 BN by 2030 from USD 3.6 BN in 2022 with a CAGR of 23.5% under the study period 2023 - 2030.

Digital biomarkers refer to measurable and quantifiable health-related data collected through digital devices and technologies, including wearables, smartphones, sensors, and other connected tools. These data points are used to monitor and analyze various aspects of an individual's health and behaviour in real time. These biomarkers provide valuable insights into a person's physiological, psychological, and behavioural patterns, enabling healthcare professionals and researchers to obtain a more holistic understanding of their well-being.

MARKET DYNAMICS:

The Digital biomarkers market is experiencing robust growth due to a combination of factors propelling the integration of technology into healthcare. Advancements in wearable devices, remote monitoring, and data analytics enable the collection of real-time health data, forming the basis for digital biomarkers. These biomarkers facilitate personalized healthcare, preventive approaches, and early detection of health issues. The wide adoption of smartphones, coupled with an ageing population and rising chronic diseases, fuels the demand for remote monitoring solutions. These biomarkers also find utility in mental health monitoring and clinical trials, while regulatory support and consumer awareness further drive their adoption. Nonetheless, challenges like data privacy and accuracy necessitate attention. The convergence of technology, healthcare needs, and patient empowerment underpins the expanding Digital biomarkers market, revolutionizing healthcare delivery and research methodologies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of digital biomarkers. The growth and trends of digital biomarkers industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the digital biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Wearable
  • Mobile Based Applications
  • Sensors
  • Others

By Clinical Practice

  • Diagnostic Digital Biomarkers
  • Monitoring Digital Biomarkers
  • Predictive And Prognostic Digital Biomarkers
  • Other'S (Safety, Pharmaco Dynamics/ Response, Susceptibility)

By Therapeutic Area

  • Cardiovascular And Metabolic Disorders (CVMD)
  • Respiratory Disorders
  • Psychiatric Disorders
  • Sleep & Movement Disease
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Others (Diabetes, Pain Management)

By End-Use

  • Healthcare Companies
  • Healthcare Providers
  • Payers
  • Others (Patient, Caregivers)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Digital Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Digital Biomarkers market include ActiGraph LLC, AliveCor Inc., Koneksa, Altoida Inc., Amgen Inc., Biogen Inc., Empatica Inc., Vivo Sense, IXICO plc, Adherium Limited, Neurotrack Technologies, Inc., Aural Analytic, Huma, Sonde Health, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DIGITAL BIOMARKERS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Clinical Practice
    • 3.7.3 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Wearable Historic and Forecast Sales by Regions
  • 5.5 Mobile Based Applications Historic and Forecast Sales by Regions
  • 5.6 Sensors Historic and Forecast Sales by Regions
  • 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY CLINICAL PRACTICE

  • 6.1 Overview by Clinical Practice
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Clinical Practice
  • 6.4 Diagnostic Digital Biomarkers Historic and Forecast Sales by Regions
  • 6.5 Monitoring Digital Biomarkers Historic and Forecast Sales by Regions
  • 6.6 Predictive And Prognostic Digital Biomarkers Historic and Forecast Sales by Regions
  • 6.7 Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Historic and Forecast Sales by Regions

7 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY THERAPEUTIC AREA

  • 7.1 Overview by Therapeutic Area
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Therapeutic Area
  • 7.4 Cardiovascular And Metabolic Disorders (CVMD) Historic and Forecast Sales by Regions
  • 7.5 Respiratory Disorders Historic and Forecast Sales by Regions
  • 7.6 Psychiatric Disorders Historic and Forecast Sales by Regions
  • 7.7 Sleep & Movement Disease Historic and Forecast Sales by Regions
  • 7.8 Neurological Disorders Historic and Forecast Sales by Regions
  • 7.9 Musculoskeletal Disorders Historic and Forecast Sales by Regions
  • 7.10. Others (Diabetes, Pain Management) Historic and Forecast Sales by Regions

8 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY END-USE

  • 8.1 Overview by End-Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-Use
  • 8.4 Healthcare Companies Historic and Forecast Sales by Regions
  • 8.5 Healthcare Providers Historic and Forecast Sales by Regions
  • 8.6 Payers Historic and Forecast Sales by Regions
  • 8.7 Others (Patient, Caregivers) Historic and Forecast Sales by Regions

9 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE DIGITAL BIOMARKERS COMPANIES

  • 10.1. Digital Biomarkers Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF DIGITAL BIOMARKERS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. ActiGraph LLC
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. AliveCor Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Koneksa
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Altoida Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Amgen Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Biogen Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Empatica Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Vivo Sense
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. IXICO plc
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Adherium Limited
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Neurotrack Technologies Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Aural Analytic
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Huma
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Sonde Health Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Wearable Market Sales by Geography (USD MN)
  • Mobile Based Applications Market Sales by Geography (USD MN)
  • Sensors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales by Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Market Sales by Geography (USD MN)
  • Analysis by Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Psychiatric Disorders Market Sales by Geography (USD MN)
  • Sleep & Movement Disease Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Musculoskeletal Disorders Market Sales by Geography (USD MN)
  • Others (Diabetes, Pain Management) Market Sales by Geography (USD MN)
  • Analysis by End-Use (USD MN)
  • Healthcare Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Payers Market Sales by Geography (USD MN)
  • Others (Patient, Caregivers) Market Sales by Geography (USD MN)
  • Global Digital Biomarkers Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Digital Biomarkers Report
  • Market Research Process
  • Market Research Methodology
  • Global Digital Biomarkers Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Clinical Practice
  • Market Attractiveness Analysis by Therapeutic Area
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Wearable Market Sales by Geography (USD MN)
  • Mobile Based Applications Market Sales by Geography (USD MN)
  • Sensors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales by Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Market Sales by Geography (USD MN)
  • Global Market Analysis by Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Psychiatric Disorders Market Sales by Geography (USD MN)
  • Sleep & Movement Disease Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Musculoskeletal Disorders Market Sales by Geography (USD MN)
  • Others (Diabetes, Pain Management) Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Healthcare Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Payers Market Sales by Geography (USD MN)
  • Others (Patient, Caregivers) Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.